Introduction
Acute kidney injury (AKI) is defined as a rapid decrease in glomerular filtration rate (GFR) caused by both vascular and tubular factors, including increased renal vasoconstriction, loss of autoregulation and tubular obstruction [1, 2] . Although incidence rates are decreasing, AKI is still associated with a high mortality rate. Nevertheless, the kidney has a remarkable regenerative capacity and is able to recover completely after renal failure. Ischemia reperfusion injury is the major cause of AKI, and after an ischemic event different processes are involved in the restoration of renal function. First, tubular epithelial cells have the ability to proliferate very rapidly and to migrate to the outer medulla where the majority of injury is observed [3] . Secondary to proliferation, tubular cells can dedifferentiate into a more mesenchymal cell type [4] and spread to the damaged area. In addition, bone marrow-derived stem cells may contribute to the regeneration of renal damage [5, 6] .
Because stem cells have powerful self-renewing and tissue-regenerating properties they provide promising new therapeutic approaches for many unmet medical needs. Traditionally, stem cells were believed to be lineage-restricted and organ-specific. However, recent studies have demonstrated that bone marrow-derived hematopoietic stem cells are capable of forming functional components of other organ tissues, like skeletal muscle [7] , heart [8] , liver [9] and kidney [5, 6, 10] . In addition, after tissue injury, differentiation of hematopoietic stem cells into parenchymal cells seems to be stimulated, suggesting that these adult stem cells may also contribute to tissue repair. This review gives an overview of the techniques used in mice to study the role of bone marrow-derived stem cells in renal regeneration, which are summarized in table 1 . We critically compare our protocol developed for induction of acute ischemic kidney injury and full bone marrow cell transplantation with other published methods in order to gain more insight into renal regeneration by stem cells.
Isolation of Bone Marrow Cells and Transplantation
Freshly isolated bone marrow cells are used in all studies that investigate the regeneration potential of the stem cells they contain. We isolated full bone marrow by flushing the femurs and tibiae of the donor mice with medium or PBS. Bone marrow can also be isolated by mincing the bones in very small pieces followed by collagenase treatment [11] . This procedure is likely to be equally effective but is more time-consuming. The isolated cells can be transplanted directly, or cultured and labeled prior to transplantation [3, 5, 11] . In our study, isolated bone marrow cells were cultured and labeled with enhanced green fluorescent protein (eGFP). Upon culturing, it is a prerequisite that cells remain in the primitive stage, which can be achieved by addition of several specific growth factors, including thrombopoietin, stem cell factor and hematopoiesis blockers like transforming growth factor-␤ . To prevent host-versus-graft reaction, donor mice should be of the same strain to exclusively study the regenerative capacity of the bone marrow. After transplantation, donor bone marrow-derived cells have to be identified and discriminated from host cells. For that purpose, different labeling procedures have been described in the literature, the most effective of which are generation of chimeric mice (LacZ, eGFP, male/female mismatching) after transplantation.
Bone marrow transplantation can be performed with different cell populations. We used full bone marrow, but transplantations of the purified stem cell fraction, Lin -Sca-1 + c-kit + (KSL), have been described as well [5, 10] . The KSL markers are typical for a primitive population of cells in the bone marrow with a high reconstitution capacity [12, 13] . The KSL fraction can be isolated [5] ). Lethal irradiation of recipient animals increases the risk of (postoperative) infections, but minimizes the influence of endogenous bone marrow. As a result, a more reliable prediction of the influence of bone marrow cells in the regeneration processes is obtained. However, this may also be achieved after sublethal irradiation of the mice followed by transplantation of labeled bone marrow cells. In addition, high irradiation doses can cause tissue damage and promote cell fusion, which leads to falsepositive results [14] . After testing both methods, we preferred sublethal irradiation because of the improved health condition and survival rate of the animals. After irradiation, we transplanted 1 million eGFP-labeled bone marrow cells in recipient animals via tail vein injection, which is the most commonly used method. The quantity of transplanted cells varies between 200,000 and 5,000,000 for full bone marrow and for a KSL fraction an amount of 20,000-30,000 cells is often used [5, 6, 10, 15, 16] . An advantage of KSL-selected cells is the specificity of this traditional bone marrow stem cell fraction. However, other stem cell fractions with a high differentiation potential, like multipotent adult progenitor cells (Lin -Sca-1 low c-kit -) [17] , are excluded during KSL selection. A major advantage of using full bone marrow is that supporting cells are transplanted as well. This may contribute to a more stable population and, eventually, a more successful and reliable transplantation outcome.
Induction of Renal Ischemic Injury to Study Bone Marrow-Derived Stem Cell Mobilization
After a harmful insult, bone marrow-derived stem cells are mobilized to the damaged tissue where they differentiate into a specific phenotype for regeneration [5] [6] [7] [8] 18] . Renal ischemia followed by reperfusion induces AKI, which triggers off the mobilization of bone marrow-derived stem cells. Nephrotoxicants like mercuric chloride (HgCl 2 ) [19] , gentamicin or cisplatin [20] [21] [22] are occasionally used to study the role of bone marrow-derived stem cells in renal repair. We induced AKI by applying a clamp on the renal artery and vein for 30 min. Prior to the induction of renal ischemic injury, mice were anesthetized with isoflurane and renal arteries and veins were exposed by an incision at the flank. Alternatively, a midline incision through the abdomen can be made. The extent of ischemic damage is comparable for both methods; however, an abdominal incision increases the risk of complications. Moreover, postoperative pain medication can be minimized after a flank incision. The clamping time is variable and depends on the strain of mice used [5, 10] . Depending on the extent of kidney injury, renal tubules regenerate with varying degrees of functional and structural recovery [23] . Histological examinations are required to confirm the degree of injury after ischemia. The ideal time point to induce renal ischemia after bone marrow transplantation is rather difficult to adjust. Ischemia can be induced directly after irradiation and transplantation [5, 10] , but also after a longer period of time [3] . Inducing ischemia directly after transplantation and, consequently, also shortly after irradiation, is often associated with postoperative infections due to bone marrow deprivation [5] . Obviously, this limits the transplantation success. Moreover, after a longer time period it is expected that donor bone marrow cells move to the recipient bone marrow following spreading in the circulation. From that point of view, cells are able to react to ischemic signals and migrate to the site of injury, which might be less stressful for the transplanted cells although this has not been described. In our study, AKI was induced 4 weeks after bone marrow transplantation. Animal health improvement and survival rate were decisive for the protocol that was chosen eventually.
Contribution of Bone Marrow-Derived Stem Cells to Renal Regeneration
For quantification of the involvement of bone marrow-derived stem cells in renal tissue regeneration, different detection methods have been described. They are based on either cell labeling (e.g. with LacZ, eGFP) or gender mismatching [3] . These techniques have all been proven reliable, however, false-positive results were reported for gender mismatching caused by non-specific binding of probe aggregates [3, 10] . For the cell labeling it should be noticed that positively stained cells are all derived from bone marrow but may not necessarily be labeled tubular cells. These false-positive results are most often caused by labeled leukocytes. This can, however, be prevented by performing a counterstaining of leukocytes with anti-CD45 antibodies or by antibodies directed against cell-specific markers, e.g. megalin for tubular cells. In addition, utilization of confocal microscopy in the analysis of bone marrow-derived cells is recommended. A confounder of eGFP detection may be a high auto-fluorescence of renal cells [24] , therefore, the use of a primary antibody directed against GFP is recommended to raise the fluorescent signal above background levels.
After renal ischemic injury we observed that approximately 10% of the integral tubular segments originated from transplanted bone marrow cells, which confirmed the results described in other publications [5, 10] . Figure 1 is a representative image of the infiltration of eGFP-labeled bone marrow-derived cells 7 days after ischemia-reperfusion injury. This was confirmed in gen- der-mismatched chimeras in which bone marrow-derived cells were recruited to renal tubules ( fig. 2 ) . In accordance with Li et al. [25] , fusion of stem cells with somatic cells does not account for the majority of the conversion of bone marrow cells to renal cells after ischemic injury. Western blot analysis can be used to quantify the amount of eGFP-positive bone marrow-derived cells in the kidney. A critical note, however, is that Western blot analysis can only differentiate between eGFP/ LacZ expression in tubular cells or in leukocytes when the kidney is perfused before isolation. Inflammatory processes often play a significant role in the pathophysiology of AKI causing, among others, outer medullary congestion [2] . Consequently, erythrocytes stick to the outer medulla, which hampers the perfusion procedure. In addition, attention should be paid to single tubularlike cells derived from the transplanted bone marrow, because these cells may also originate from donor leukocytes that fuse with residing tubular cells. To overcome these limitations, different identification techniques should be employed to confirm the findings. Renal function tests are required to determine the outcome of the regeneration process. The most common functional parameters used are creatinine clearance and blood urea nitrogen (BUN) concentration [5, 26] . Creatinine clearance is a widely accepted parameter for GFR assessment, although one should be cautious for misinterpretations caused by inadequate urine collection and differences in creatinine production. A decreased creatinine clearance accompanied by an unchanged serum creatinine concentration can be caused by inadequate urine collection. In addition, production of creatinine differs among and within individuals over time, depending on dietary intake (vegetarian diet, creatine supplements) or muscle mass. In this case, determinations of the renal clearance of inulin or other exogenous compounds, such as iothalamate, iohexol, or DTPA, are more reliable markers of GFR [27] [28] [29] . Individual variations in mice are, however, easy to exclude by using control animals which are genetically identical and are housed under the same conditions. Using our research protocol, a decreased creatinine clearance was observed 2 days after the induction of ischemia (p ! 0.001), which returned to near normal levels on day 7 postischemia (data not shown).
The BUN concentration, on the other hand, is not as reliable as creatinine clearance, because it can vary independently of GFR changes due to variations in the rate of urea production. For example, a high protein diet results in an increase in BUN, as does enhanced tissue breakdown due to hemorrhage, trauma or corticosteroids.
Whenever BUN values are used to predict renal function, additional tests, like creatinine clearance or fractional sodium excretion, should be performed to get a more reliable assessment of renal function.
Conclusions
Considerable progress has been made in the development of different techniques to study the role of bone marrow-derived stem cells in ischemia-induced AKI. Using the method described in this review, we have shown that at least 10% of the regenerated proximal tubular segments originate from donor bone marrow. However, controversial results have been reported in the literature, mainly originating from differences in experimental models. We have listed the currently available techniques in table 1 to aid in the selection of the most appropriate experimental model. Bone marrow consists of several stem cell populations and the specific types responsible for regeneration of damaged kidney tissue are still not known. It is likely that more subpopulations are responsible for this process, but their contribution has yet to be investigated by transplantation of the purified fractions.
To study the regeneration process in vivo, mice should be in a good health condition to prevent the influence of other confounding factors. To achieve this, AKI should not be induced sooner than a few weeks after transplantation. In addition to a better physical condition of the recipient mice, a longer period between transplantation and injury induction is also beneficial for the regeneration process. Moreover, a longer time period allows cells to spread and migrate in the circulation, and to reconstitute the bone marrow.
Finally, to assess the overall contribution of bone marrow-derived stem cells in kidney regeneration, several methods can be applied, of which immunohistochemistry is the most reliable technique. An important issue is the exclusion of false-positive cells. The use of confocal microscopy and (double) staining of the kidney samples in quantitative analysis and the gender-mismatching procedure in donor and recipient mice reduces the chance of false-positive results. The outcome of kidney renewal after acute injury can be investigated by several functional tests. Although these tests do not cover the contribution of bone marrow cells, they give detailed information about the progression of the regeneration process and help in the comparison of different protocols.
The use of appropriate in vivo models accompanied with more in vitro data about the differentiation process from stem cell into renal cell, will provide research tools to obtain more mechanistic insight in the regeneration process. Yet, the development of an in vitro assay, in which cultured renal cells differentiate from primitive stem cells, is still a major challenge. Within the bone marrow, several stem cell populations have pluripotent characteristics. Transplantations with the hematopoietic stem cell population or mesenchymal stem cell population did not improve the renal repair process, but a third cell population, the multipotent adult progenitor cells, may still be promising [17] . This cell type might have the capacity to differentiate in vitro towards renal cells, and eventually could provide a valuable source of cells for transplantation and therapy. However, the kidney consists of a very heterogeneous cell population. At this moment an in vitro assay cannot imitate the complexity of kidney development in vivo, which limits the use of cultured renal cells for our research questions. The transplantation of bone marrow-derived stem cells in vivo is, however, promising and opens new possibilities for cellular therapies of renal disease. Autologous transplantation of stem cells may evidently minimize the use of donor organs and immunosuppressants, and possibly maximizes the success of tissue remodeling. Obviously, this is a next challenge to regeneration science.
